Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Open in API
Filings indexed 331 across all filing types
Latest filing 2025-05-09 Regulatory Filings
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
Contract Award with New UK Client
Regulatory Filings Classification · 1% confidence The document is a press release issued via the Regulatory News Service (RNS) announcing a new contract award for Physiomics plc. It does not fit into specific categories like financial reports, board changes, or dividend announcements. As it is a general corporate announcement regarding business operations (a contract win) that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2025-05-09 English
AIM Rule 17 and Schedule 2(g) Update
Director's Dealing Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement regarding a director's disclosure under AIM Rule 17. It specifically details a change in the status of a company where a Physiomics PLC director holds an executive position (Oxford Cannabinoid Technologies Holdings plc entering administration). This falls under the category of board/management information as it pertains to director disclosures and regulatory compliance regarding board members.
2025-05-07 English
Physiomics Awarded New Contract
Regulatory Filings Classification · 1% confidence The document is a press release issued via the RNS (Regulatory News Service) platform announcing a new contract award for Physiomics plc. It does not fit into specific categories like financial reports, board changes, or shareholder voting. As it is a general corporate announcement regarding business operations (a new contract) that does not fall into the other specialized categories, it is classified as a general regulatory filing.
2025-04-17 English
Publication of Peer Reviewed Article
Regulatory Filings Classification · 1% confidence The document is a press release distributed via the RNS Reach service announcing the publication of a peer-reviewed scientific article in the Journal of Molecular Cancer Therapeutics. It does not contain financial results, governance updates, or regulatory filings required by law, but rather serves as a corporate news update regarding research collaboration. As it does not fit into specific categories like 10-K, ER, or RNS (which is reserved for regulatory announcements), it falls under the fallback category for general regulatory/corporate announcements.
2025-04-16 English
Contract Award
Regulatory Filings Classification · 1% confidence The document is a press release distributed via the RNS (Regulatory News Service) platform announcing a new business contract between Physiomics plc and Numab Therapeutics. It does not fit into specific categories like financial reports, board changes, or shareholder voting. As it is a general corporate announcement regarding business operations, it falls under the RNS regulatory filing category.
2025-04-15 English
Contract Award with new client
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 8990A' and concludes with standard RNS disclaimers, indicating it is a regulatory news service announcement from the London Stock Exchange. The content announces a 'Contract Award with new client' and provides details about the contract value and timeline. This type of announcement, which is a general corporate update that doesn't fit into specific categories like earnings (ER), director dealings (DIRS), or capital changes (CAP), is best classified under the general regulatory announcement category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a standard RNS news item that is not a specific financial report or corporate action disclosure. The document length (3177 chars) is short, but it is an announcement of an event (contract award), not an announcement *about* the publication of a major report, so RPA is less suitable than RNS for this type of operational news.
2025-03-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.